Biotech Industry Intelligence

Collegium is acquiring Corium’s approved ADHD drug for $650M

Collegium is acquiring Corium’s approved ADHD drug for $650M

Published

3 weeks ago

on

March 19, 2026

By

Temp User

Collegium Pharmaceutical is beefing up its portfolio in ADHD with the acquisition of Corium’s FDA-approved drug Azstarys.

The $650 million upfront deal carries up to an additional $135 million in milestones and is expected to … Read More

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Contributors9 years ago

The final 6 ‘Game of Thrones’ episodes might feel like a full season
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Uncategorized9 years ago

The old and New Edition cast comes together to perform
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State

Exit mobile version